Related by context. All words. (Click for frequent words.) 61 blinded placebo controlled 60 placebo controlled dose escalation 60 recombinant PSMA vaccine 60 controlled dose escalation 59 HCV NS5B polymerase 58 multinational multicenter randomized 58 CEL SCI Phase III 57 solid tumors ZYBRESTAT 57 opioid naive 57 controlled multicenter 57 EXPLORE Xa 57 malignant mesothelioma Alfacell 57 Budesonide foam crofelemer 56 cancer indications bafetinib 56 EQUIP OB 56 double blinded randomized 56 AAG geldanamycin analog 56 pharmacogenomic translational research 56 recurrent metastatic ovarian cancer 56 double blinded placebo 55 placebo controlled randomized 55 CTA# Injection 55 EQUATE OB 55 double blind placebo 55 blinded randomized placebo controlled 55 evaluating adecatumumab 55 cardiac myosin activator omecamtiv 55 blind placebo controlled 55 humanized therapeutic 55 ABSORB clinical 54 QNEXA ® 54 intravenous belinostat 54 blind randomized 54 blinded randomized 54 clinical trials Archexin 54 TG MV 54 randomized multicenter 54 specific CCR9 antagonist 54 Transgenomic Pharmacogenomics Services 54 Randomized Double blind 54 clinic automation LabPas 54 dimebon latrepirdine 54 landmark ATHENA 53 randomized placebo controlled 53 Hypertensive adverse reactions 53 RAS MAPK pathway 53 comparing XIENCE V 53 registrational Phase 53 number NCT# ClinicalTrials.gov 53 CYT# potent vascular disrupting 53 blind randomized placebo 53 intravenous RSD# 53 placebo controlled multicenter 53 RECORD1 53 REVIVE TA 53 Inc. MSVLP 53 CLL8 53 Blind Placebo Controlled 53 pralatrexate injection folate analogue 53 Mg Usa 53 multicenter multinational 53 By JENNIFER LEARN 53 Empatic ™ 53 iobenguane 53 EOquin TM phase 53 multicenter randomized double 53 randomized controlled 53 multicenter placebo controlled 53 infliximab monotherapy 53 rash pruritus nausea 53 blind multicenter 53 multicenter study 53 multicenter Phase III 53 SORT OUT III 53 Randomized Study 53 treatment naïve genotype 53 multicenter randomized placebo controlled 52 placebo controlled Phase III 52 migraine headaches AZ 52 placebo controlled 52 Placebo Controlled 52 ASH Abstract # 52 Securities LP HFFS 52 combines bupropion 52 TMC# C# 52 Curis collaborator Genentech 52 DIRECT Trial 52 dose dose escalation 52 budesonide MMX Phase III 52 6 sulfatase 52 prospective observational 52 evaluating T DM1 52 deCODE AF TM 52 multicentre 52 observer blinded randomized 52 Contrave# 52 Crofelemer budesonide foam 52 randomized blinded 52 Electrophysiology Cardiovascular Surgery 52 DG# compounds targeting 52 blind placebo 52 PLX STROKE targeting 52 PMX # heptagonist 52 worsening thrombocytopenia 52 retinal thrombosis hemorrhages 52 TRIOLEX HE# APOPTONE HE# 52 Obatoclax 52 Phase IIb randomized 51 RG# ITMN 51 isolated hypertriglyceridemia 51 novel chimeric natriuretic 51 CYP#A# CYP#D# 51 Cannabinor 51 ragweed allergy immunotherapeutic 51 oral rivaroxaban 51 multicenter randomized 51 pharmacologically active isomer 51 testing huN# DM1 51 evaluating tivozanib 51 prasterone 51 masked placebo controlled 51 virus HCV protease inhibitor 51 including cyclosporine methotrexate 51 CML CP 51 sulfonylurea glimepiride 51 Staccato prochlorperazine 51 active comparator 51 pontiff forgave 51 multicentre randomized 51 phase Ib 51 primary hypercholesterolemia 51 systemic lupus erythematosus rheumatoid 51 Mg Uk 51 naloxol derivative 51 randomized double 51 multicentre randomized double 51 R ferumoxytol Injection 51 Trial Evaluating 51 Telik logo TELINTRA 51 Selzentry Celsentri 51 unique alkylating agent 51 stage IIIb IV 51 evaluating picoplatin 51 Edge STudy 51 undergoing elective percutaneous 51 International Verapamil SR 51 UDBL #/#/# #:# 51 Clinical Antipsychotic Trials 51 relapsed MM 50 AVOREN 50 IMiDs ® 50 Sorafenib HCC Assessment 50 MKC# MT 50 coronary stent merged 50 Sapacitabine 50 novel VDA molecule 50 Initiated Phase 50 Randomized Phase II 50 Fovea Pharmaceuticals subsidiary 50 prospective randomized placebo 50 Epothilone D 50 relapsed myeloma 50 dependent kinase inhibitor 50 LymphoStat B belimumab 50 randomized clinical 50 includes TOLAMBA TM 50 placebo controlled Phase 50 developing Bicifadine serotonin 50 trials RCTs 50 MyECheck utilizes patented 50 randomized controlled multicenter 50 mg q#h 50 brand ciclesonide HFA 50 decompensated liver disease 50 orally inhaled migraine 50 PORxin TM platforms 50 Oral Fingolimod 50 class mGluR5 inhibitor 50 randomized 50 rubble strewn roundabout 50 Combination REOLYSIN R 50 Hopper costarred 50 prospective randomized multicenter 50 tolerability pharmacokinetics 50 development peramivir neuraminidase 50 multicenter prospective 50 clinical trials Archexin ® 50 Locteron ® 50 Imetelstat 50 Phase Ib clinical trials 50 multicenter 50 Meets Primary Endpoint 50 lenalidomide Revlimid ® 50 Randomized Phase 50 non constipating irritable 50 GATTEX ™ 50 ASG 5ME dacetuzumab SGN 50 RESTORE CLI trial 50 maximally tolerated dose 50 Phase III randomized 49 Oral NKTR 49 memantine HCl 49 HCV SPRINT 49 weekly subcutaneous injections 49 FOLFOX6 chemotherapy regimen 49 AIR CF2 49 backed Ustasha regime 49 NO# [002] 49 humanized interleukin 6 49 including Bayer Celldex 49 Cholesterol Levels SPARCL 49 randomized multicenter trial 49 ACTEMRA TM 49 kidney urologic 49 Ovitrelle R Serostim 49 VEGFR2 inhibitor 49 azilsartan medoxomil 49 rheumatoid arthritis psoriatic arthritis 49 Study Evaluating 49 sorafenib tablets 49 ORAL Solo 49 Pruvel TM 49 multicentre study 49 Testosterone MDTS R 49 safety tolerability pharmacokinetics 49 Multicenter Phase 49 Phase III placebo controlled 49 Randomized Double Blind 49 REVIVE Diabetes 49 ENL recurrence 49 somatostatin analog 49 Methylnaltrexone 49 CYPHER R stent 49 metastatic HRPC 49 multicenter dose escalation 49 Communities ARIC study 49 IIa clinical 49 label multicenter 49 GetGoal Phase III 49 targeted protein kinase 49 oral FTY# 49 randomized controlled clinical 49 Young Adults CARDIA 49 RIO Lipids 49 dose escalation phase 49 symptomatic BPH 49 BRIM3 49 mg Pycnogenol 49 BR.# 49 dose escalation trial 49 Rigel R# 49 rALLy clinical trial 49 hyperphenylalaninemia HPA due 49 Bayer HealthCare Onyx Pharmaceuticals 49 Subgroup Analysis 49 ongoing Phase 1b 49 Randomised 49 aflibercept VEGF Trap 49 riociguat 49 INSPIRE Trial Phase III 49 Ribavirin causes 49 oral chemotherapeutic agent 49 bone marrow reticulin deposition 49 virologically suppressed 49 antidepressants fluoxetine 49 EMPOWER ™ 49 Pharma Merck Serono 49 XL# anticancer compounds 48 trial evaluating PRX# 48 plus prednisone prednisolone 48 overnight polysomnography 48 plus Copegus R 48 Kevin Kistner 48 Trandolapril 48 phase IIb clinical 48 maximize aerodynamic drag 48 trastuzumab Herceptin R 48 Randomized Double Blind Placebo 48 CSAMT MT survey 48 relapsing remitting MS RRMS 48 Aplidin R 48 Arterial stiffness 48 designated HVTN 48 dose escalation clinical 48 Kefaya Change 48 safety tolerability pharmacokinetic 48 DepoCyt ® Abelcet ® 48 Tocilizumab 48 PEGylated docetaxel 48 Tekturna HCT ® 48 PEGINTRON TM 48 prospective randomized controlled 48 next generation URAT1 48 Prescription acetaminophen 48 sodium glucose cotransporter 48 naïve HCV 48 Raptiva r 48 topical antifungal product 48 ascending dose 48 MEK Inhibitor 48 ExTRACT TIMI 48 CONQUER OB 48 Wisconsin Sleep Cohort 48 Intervention Effectiveness 48 multicenter Phase II 48 albiglutide 48 TO AVOID PREGNANCY WHILE 48 initiate multicenter 48 blind randomized multicenter 48 randomized blinded placebo 48 male Wistar rats 48 Pivotal Phase 48 diagnosed Ph + 48 myocardial infarction ventricular fibrillation 48 lintuzumab SGN 48 imetelstat GRN#L 48 inhalations twice 48 mg dosed once 48 Safinamide 48 Multicentre 48 pivotal bioequivalence 48 dyskinesia PD LID 48 vapreotide acetate 48 nonrandomized 48 sequential dose escalation 48 oral Janus kinase 48 oral prodrug 48 multicentre prospective 48 trials BLISS 48 COMFORT II 48 ZYBRESTAT fosbretabulin 48 EchoCRT 48 receptor tyrosine kinase inhibitor 48 venlafaxine XR 48 Lodotra TM 48 Sammy Labana apxfire@yahoo.com 48 Maximum Tolerated Dose MTD 48 HGS ETR1 mapatumumab 48 bile duct tumor 48 RoACTEMRA 48 mg OSMOPREP ® 47 headache nasopharyngitis 47 sapacitabine CYC# 47 sorafenib Nexavar ® 47 phase IIb study 47 IMiDs ® compound 47 MET amplification 47 IAP inhibitor 47 pan histone deacetylase 47 RE LY ® 47 Cardiac Allograft Rejection 47 dose escalation Phase 47 Pat McGatt 47 Phase III Clinical Trial 47 Microplasmin 47 refractory chronic lymphocytic 47 Qnexa TM 47 Kinesin Spindle Protein KSP 47 Kaspar robot 47 skeletal sarcomere activators 47 Bridgette Meinhold #/#/# 47 Myocardial Infarction Study 47 phase III ACCLAIM 47 RANK Ligand inhibitor 47 liposomal formulation 47 drugs cough suppressant 47 mg RDEA# 47 network TIO symbolizes 47 recurrent malignant glioma 47 granted Ortec 47 Completes Patient Enrollment 47 AIR2 Trial 47 PEG INTRON R 47 PEGINTRON REBETOL combination 47 pan HDAC inhibitor 47 system REG1 consists 47 multicenter phase 47 nilotinib Tasigna ® 47 rilonacept Injection 47 R rilonacept Injection 47 iloprost synthetic compound 47 cyclophosphamide doxorubicin vincristine 47 controlled multicenter Phase 47 Atripla combines 47 Vidaza ® 47 metaglidasen 47 PET FROM 47 Serostim ® 47 ORACLE MS 47 mGluR5 negative 47 dwayne tingley 47 randomized controlled clinical trials 47 prednisone CHOP 47 R Everolimus Eluting 47 de novo kidney transplant 47 LEXIVA r 47 TRANSDUR ® 47 single ascending dose 47 lenalidomide Revlimid R 47 INTEGRILIN R 47 Serious adverse reactions 47 vaccinated PNH patients 47 delta opioid receptor 47 phase IIb trial 47 investigational monoclonal antibody 47 TELINTRA R 47 label multicenter randomized 47 investigational oral 47 pharmacodynamic profiles 47 Completes Enrollment 47 By Louise Bellicoso 47 systemic juvenile idiopathic 47 doomed Cedric Diggory 47 Initiates Phase II 47 sarcoma melanoma 47 prednisone prednisolone plus 47 ramipril Altace 47 MSI #F 47 familial amyloidotic polyneuropathy FAP 47 cisplatin gemcitabine 47 placebo controlled clinical 47 erlotinib Tarceva R 47 ATRA IV 47 Sasha Gelf 47 Altera Nebulizer System 47 sorafenib Nexavar R 47 Sanofi Pasteur Fluzone 47 acyclovir Lauriad R 47 Parkinson disease levodopa induced 47 OfficialWire NewsDesk 47 aplindore 47 Naive Patients 47 Paul Cachia pcachia@di-ve.com 47 Company TAIFUN R 47 priest Zebedee 47 Dave Goodban Flintshire Chronicle 47 pegylated interferon alfa 2a 47 candidate oral AP# 47 prospective multicenter 47 evaluating REVLIMID 47 autoantibody positive 47 dietary questionnaires 47 LUX Lung 47 BRIM2 47 Matrix Phase 2b 47 anionic backbone 47 landmark ATHENA study 47 Phase III multicenter 47 monoclonal antibody IgG1 Mab 47 constipation OIC 47 label dose escalation 47 toenail onychomycosis 47 Flamel Medusa R 47 Prospective Randomized 47 either acutely decompensated 47 Aztreonam lysine 46 AKT inhibitor 46 ocular formulation 46 Nikisha Smith 46 evaluating mipomersen 46 Overriding veto requires 46 PI3K/Akt pathway inhibitor 46 DU #b 46 molecules Immune SIMULATORS 46 EDITORS NOTE Virgin 46 GATTEX ® 46 Broadway.com Staff 46 Silar Advisors LP 46 Amrubicin 46 sunitinib Sutent ® 46 patients undergoing percutaneous 46 Diamyd ® 46 telaprevir dosed 46 nab paclitaxel 46 vitamin B# folic acid 46 q8h 46 ExpatForum.com 46 desvenlafaxine succinate 46 vinca alkaloid 46 davunetide intranasal AL 46 CYT# QbG# 46 diabetic neuropathic pain 46 dihydroergotamine DHE 46 dexamethasone Decadron 46 COLAZAL ® 46 prospective randomized 46 dasatinib Sprycel ® 46 evaluating carfilzomib 46 Val HeFT 46 irinotecan doxorubicin oxaliplatin paclitaxel 46 Neovascular AMD 46 dirucotide MBP# 46 Initiate Phase 46 Prostate Lung Colorectal 46 Multi Ethnic Study 46 intravesical infusion therapy 46 known dihydropyrimidine dehydrogenase 46 Elagolix 46 MKC# MKC# PP 46 oral dual endothelin 46 relapsed refractory multiple myeloma 46 prospective cohort 46 mertansine 46 Pharmos pipeline 46 leading oral taxane 46 Ranolazine 46 recurrent glioma 46 Endovascular Valve Edge 46 placebo controlled trials 46 NOXAFIL Oral Suspension 46 ascending doses 46 CIMZIA ™ 46 HCV RESPOND 2 46 #/#/# Cytokinetics Incorporated 46 Hsp# Inhibitor 46 placebo controlled clinical trials 46 Luveris R Ovidrel R 46 EmbraceAC 46 mcg albinterferon alfa 2b 46 metformin sulfonylurea 46 undergone radical prostatectomy 46 FUSILEV enhances 46 ceftazidime 46 Screening Trial 46 Multicenter 46 Matrox Bring 46 compound INCB# 46 var arrContent = 46 bevirimat Study 46 pharmacodynamic properties 46 comparing alemtuzumab 46 induced macular edema 46 μg dose 46 Pivotal Phase III 46 Jemin B. Guillermo 46 Primary endpoints 46 randomized Phase III 46 mg TID 46 NewsDesk iWireNews ™ 46 operation Suzhou Erye 46 8mg/kg 46 Ophena TM 46 leopard mountain lion 46 angiotensin analog 46 IIa clinical trials 46 AVE# 46 specific ZFP Nucleases 46 venlafaxine ER 46 Debtaru De 46 bepotastine besilate nasal spray 46 Tarvacin Anti Cancer 46 markets COLAZAL 46 BiTE R 46 INVEGA ® 46 XYZAL R 46 Robin Weage 46 Randomized Placebo Controlled 46 ES Subong 46 Kit CD# positive 46 Carbon monoxide byproduct 46 Starz Media www.starzmedia.com 46 EURIDIS 46 lisa hodge 46 evaluating Actimmune 46 FOLOTYN ® 46 Carotid Revascularization Endarterectomy vs. 46 REGEN trial 46 allogeneic endothelial cells 46 prospective multicentre 46 Dapagliflozin 46 metformin HCl 46 ASCEND HF 46 EMPOWER TM 46 ALN VSP Phase 46 ® bortezomib 45 lorcaserin Phase 45 Phase IIb trial 45 Diamyd R 45 Linagliptin 45 evaluating Xcytrin 45 Cerebral Amyloid Angiopathy 45 deliver innovative biomedicines 45 myelofibrosis polycythemia vera 45 randomized crossover 45 YONDELIS 45 intravenous picoplatin 45 #:# randomization 45 CTAP# Capsules 45 ritonavir boosted 45 erlotinib Tarceva ® 45 NS5B polymerase 45 axes gyroscope 45 mg administered orally 45 blind randomized controlled 45 mixed hyperlipidemia 45 alfimeprase direct 45 MabCampath 45 sertraline Zoloft 45 #Gay.com Newscenter Staff 45 var arrMeta = 45 3 registrational trial 45 tumor xenograft models 45 Phase IIIb 45 observational cohort 45 acute coronary syndromes ACS 45 dabigatran etexilate 45 novel topoisomerase 45 Pivotal Trial 45 TAXUS ATLAS 45 AIR CF1 45 Aryplase 45 Initiates Enrollment 45 Ceflatonin R 45 MIVI III 45 HGS ETR2 45 Randomized controlled 45 ROCKET AF 45 catheter occlusion 45 RTT Staff Writer 45 IMiDs R 45 BLOOM Behavioral modification 45 safety tolerability 45 CK # administered 45 2 methoxyestradiol 45 Tarceva TM 45 FFNS 45 prokinetic agent 45 phase IIb 45 nucleoside naive 45 STRIDE PD 45 protein kinase inhibitor 45 Emtriva Viread 45 VICTOR E1 45 MT# MEDI 45 daily Infergen 45 #mg q8h 45 anti arrhythmic drug 45 morphometric vertebral fractures 45 antiangiogenesis therapies 45 sunitinib malate 45 intravenous dose 45 atrial fibrillation budiodarone ATI 45 Phase III Pivotal 45 PRTX 45 selective estrogen receptor modulator 45 galiximab 45 nucleoside polymerase inhibitor 45 placebo controlled studies 45 Pegasys ® 45 randomized controlled trial 45 interferon gamma 1b 45 Devon Jeffreys 45 CARDIA study 45 Novartis Trileptal 45 Left Ventricular Dysfunction 45 PCI ExTRACT TIMI 45 irinotecan cisplatin 45 #mg/day [001] 45 evaluating Vectibix 45 systemic Phase 1b 45 hour bronchodilation 45 Barbara Kram Editor 45 CURRENT OASIS 7 45 knhedit@kilgorenewsherald.com 45 DermaVir Patch 45 generation Hsp# inhibitor 45 stable angina pectoris 45 Phase 1b clinical 45 CINQUIL 45 visilizumab 45 rosuvastatin #mg 45 refractory NSCLC 45 label multicenter Phase 45 PREZISTA rtv 45 #mg #mg #mg [003] 45 Vytorin combines 45 AEG# 45 Telithromycin 45 MicroGear Precision Scroll Wheel 45 Playfuls Team 45 Extra.Credit 45 vesicular monoamine transporter 45 investigational HCV polymerase 45 Phase 1b trial 45 Dabigatran etexilate 45 Placebo controlled 45 PEGylated irinotecan 45 holdthefrontpage staff 45 Margarita Raycheva Staff Writer 45 SCH # 45 innovative transmucosal 45 EGFr humanized monoclonal antibody 45 decreased matrix metalloproteinase 45 Traficet EN 45 serotonin norepinephrine reuptake inhibitor 45 % pramoxine HCl 45 Ovarian PLCO Cancer 45 CHRISTINE RICCIARDI 45 Gill Montia 45 Rhetoric heats 45 saquinavir ritonavir 45 Chronic Idiopathic Constipation 45 Demonstrates Positive 45 mg subcutaneously 45 mGluR2 positive 45 neovascular form 45 Testosterone MDTS ® 45 commercializes implantable 45 ABCSG 45 MAGE A3 ASCI 45 investigational antiplatelet agent 45 valsartan amlodipine 45 UPI Wire 45 Aria Munro 45 MCSP respectively 45 orally administered inhibitor 45 Zoraxel 45 limiting toxicity DLT 45 Prostate AdenoCarcinoma Treatment 45 CVN Report 45 RezularTM 45 randomized #:# 45 Phase III Clinical Trials 45 genes gene mutations 45 rivaroxaban Xarelto 45 DEBI MARTONE 45 ginkgo biloba extract 45 Acute Ischemic Stroke 45 metastatic GIST 45 ANCHOR trial 45 Phase III metastatic melanoma 45 CATIE AD 45 CCR5 mAb 45 prospectively stratified 45 phase IIa 45 allosteric modulator NAM 45 Peginterferon 45 Diovan Exforge Tekturna Zelnorm 45 Phase Ib II 45 oral isoform selective HDAC 45 di ve.com editorial@di-ve.com 45 treatment naive genotype 45 intravenous bolus 45 Scandinavian Simvastatin Survival 44 #mg BID [001] 44 pregabalin Lyrica 44 bupropion SR 44 opioid induced bowel dysfunction 44 diarrhea predominant irritable 44 pegylated liposomal doxorubicin 44 tolerated dose MTD 44 Atherosclerosis MESA 44 chemotherapy FOLFOX 44 Phase Ib IIa 44 phase III isavuconazole 44 FOLFIRI chemotherapy 44 Nasdaq PGNX today 44 TRANSFORMS 44 label dose titration 44 Proellex TM 44 dose pharmacokinetic 44 dosing cohort 44 evaluating satraplatin 44 CAMMS# 44 HIV HCV coinfected 44 pharmacokinetics pharmacodynamics 44 systemic sclerosis SSc 44 ragweed allergic 44 trabedersen 44 Group B CALGB 44 Ceyhan Belediyesi 44 TKB# 44 TBC# 44 dosing cohorts 44 randomized controlled Phase 44 investigational humanized monoclonal antibody 44 ordered cytoskeletal 44 HDMI output #p/#i 44 randomized controlled trials 44 ancrod 44 Phase 1b clinical trials 44 Elotuzumab 44 Imprime PGG ® 44 TRITON TIMI 44 ALN HPN 44 Phase III randomized placebo 44 non valvular atrial 44 CRESTOR #mg 44 Kaliningrad sandwiched between 44 Clinical Trial Evaluating 44 Diabetic Macular Edema 44 Elwin Francis 44 including eniluracil ADH 44 Augment TM 44 Swedish Mammography Cohort 44 GAMMAGARD 44 By Ron Chimelis 44 collapsed Dincer 44 SCIg 44 retinal vein occlusion induced 44 paroxysmal AF 44 AVERROES 44 BOLDER II 44 Adenoscan R 44 TEMODAL 44 alan cochrane 44 LHRH antagonists 44 About microRNAs MicroRNAs 44 products Oncaspar ® 44 ACCEDE 44 idiopathic Parkinson disease 44 selective phosphodiesterase 44 Folfox 44 Double Blind Placebo 44 heFH 44 PSN# [002] 44 COU AA 44 Phase IIIb clinical 44 Deforolimus 44 Harry Oldfield 44 RLAI 44 Antares Pharma focuses 44 video output #p/#i/#p 44 technologically advanced F# 44 IIa trial 44 COPEGUS ribavirin 44 APTIVUS ritonavir 44 5 FU leucovorin 44 acting angiotensin 44 sulodexide 44 Phase IIb Trial 44 relapsing remitting multiple sclerosis 44 6R BH4 44 insulin detemir 44 adult chronic ITP 44 CHAMPION PCI 44 pharmacodynamic profile 44 KERRI PANCHUK 44 Vidaza R 44 WBRT alone 44 avosentan 44 Tolvaptan 44 lanthanum carbonate 44 both intercalates DNA 44 solithromycin 44 ABSORB trial 44 IBS C 44 II Clinical Trial 44 dose titration 44 LibiGel Phase III 44 pain palliation 44 Tekamlo 44 seeing pluses minuses 44 direct thrombin inhibitor 44 COSIRA trial 44 R sorafenib tablets 44 SR B1 44 evan williams 44 Punch Jump Crew 44 5 HT2A inverse 44 CANCIDAS 44 SUCCEED trial 44 randomized #:#:# 44 docetaxel Taxotere R 44 RRMS patients 44 Phase 2a Clinical Trial 44 acute mania 44 Clinical Outcomes Utilizing Revascularization 44 lexidronam injection 44 PRIMO CABG 44 pen injectors 44 Investigational eFlow Nebulizer System 44 drugs incorporating Contramid 44 retrospective observational study 44 refractory metastatic colorectal cancer 44 5 fluorouracil leucovorin 44 alvespimycin 44 Phase IIa trial 44 dose regimens 44 LITHE 44 cetuximab Erbitux R 44 TMC# [002] 44 Copegus R 44 ROZEREM TM 44 STEALTH C 44 clinical trials dacetuzumab SGN 44 Multiple Ascending Dose 44 RSD# oral 44 Shihan VMS Project 44 multicentric 44 TAXUS Element Paclitaxel Eluting 44 superficial bladder cancer 44 Randomized Controlled 44 IIa clinical trial 44 paclitaxel poliglumex 44 enzymatic reactions immunodiagnostics 44 Researchers randomly assigned 44 PRIMO CABG2 44 PRECiSE 44 Prozac fluoxetine 44 automotive airbags microfluidic 44 mocetinostat MGCD# 44 melphalan prednisone 44 Specifically CompuFlo 44 perampanel 44 noted Haldin 44 ID NCT# 44 ADVANCE PD 44 diarrhea vomiting nausea 44 Phase IIa 44 Aggressive Reduction 44 catheter occlusion CO 44 sNDA submission 44 prospectively randomized 44 peripherally acting 44 refractory CLL 44 peginterferon alfa 2b 44 investigational protease inhibitor 44 Precision Xtra Medisense Optium 44 Called Diaoyu 44 oral sapacitabine 44 histrelin manufacturing marketing 44 hypogonadal men 44 evaluating nimotuzumab 44 IL# PE#QQR 44 mg qd 44 vascular disrupting agent 44 tramiprosate Alzhemed TM 43 detector computed tomography 43 LEVAQUIN ® 43 ONTARGET 43 Controlled Trial 43 Immune Reconstitution Syndrome 43 small molecule glucokinase 43 R#/MEM # 43 Panzem NCD 43 Phase 2b randomized 43 fred meyer 43 non nucleoside inhibitor 43 Phase #/#a 43 Phase Ib study 43 eosinophilic asthma 43 prospective nonrandomized 43 pharmacokinetics PK 43 Zenvia ™ 43 ENMD # 43 Katarzyna Radzka 43 CHOP cyclophosphamide doxorubicin vincristine 43 soluble TNF receptor 43 3TC lamivudine Epivir 43 mGluR5 NAM 43 Calmare pain 43 Technosphere R 43 pitavastatin 43 Adalimumab 43 GEM OS2 43 Degarelix 43 BENICAR HCT 43 mg simvastatin 43 Genentech Boehringer Ingelheim 43 Factor Xa 43 European Sepsis Trial 43 teriflunomide 43 tenofovir emtricitabine 43 MIRAPEX ER 43 basal bolus regimen 43 Albuferon TM 43 irbesartan 43 CHOP chemotherapy 43 atorvastatin Lipitor 43 protease inhibitor PI 43 RE LY 43 Subgroup analysis 43 chronic ITP patients 43 Romiplostim 43 OMP #R# 43 multidose 43 Amirhossein Sairafi 43 investigational pan BCR 43 NPH insulin 43 FOSRENOL ® 43 microgram kg 43 cilostazol 43 Phase III ADT 43 Neulasta R 43 randomized discontinuation trial 43 ribavirin Copegus 43 generation DACH Platinum 43 fluticasone furoate 43 Damir Jovanović 43 zolmitriptan 43 QNEXA 43 clozapine Clozaril 43 indinavir Crixivan 43 aspirin clopidogrel 43 Novel Oral 43 Combo Stent 43 ritonavir boosted danoprevir 43 highly selective inhibitor